Athira Pharma's small-molecule drug is designed to specifically enhance the activity of a naturally occurring brain mechanism that has the potential to restore neuron health and brain function.
source https://www.seattletimes.com/business/technology/seattle-biotech-firm-scores-85-million-for-work-on-alzheimers-drug-despite-hurdles-of-coronavirus-pandemic/?utm_source=RSS&utm_medium=Referral&utm_campaign=RSS_technology
No comments:
Post a Comment